Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Recording ERCP fluoroscopy metrics using a multinational quality network: establishing benchmarks and examining time-related improvements.

Romagnuolo J, Cotton PB.

Am J Gastroenterol. 2013 Aug;108(8):1224-30. doi: 10.1038/ajg.2012.388.

PMID:
23912400
2.

ERCP and fluoroscopy time.

Alkhatib AA, Jalil AA, Harrison ME.

Am J Gastroenterol. 2014 Mar;109(3):447-8. doi: 10.1038/ajg.2013.470. No abstract available.

PMID:
24594961
3.

The ERCP quality network: a pilot study of benchmarking practice and performance.

Cotton PB, Romagnuolo J, Faigel DO, Aliperti G, Deal SE.

Am J Med Qual. 2013 May-Jun;28(3):256-60. doi: 10.1177/1062860612456235. Epub 2012 Aug 28.

PMID:
22930708
4.

Effect of fluoroscopy utilization monitoring on fluoroscopy times during ERCP.

Alkhatib AA, Harrison ME, Pannala R, O'Faigel D.

Minerva Gastroenterol Dietol. 2013 Jun;59(2):211-5.

PMID:
23831911
5.

Response to Alkhatib et al.

Romagnuolo J.

Am J Gastroenterol. 2014 Mar;109(3):448. doi: 10.1038/ajg.2013.475. No abstract available.

PMID:
24594963
6.

Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project.

Kapral C, Duller C, Wewalka F, Kerstan E, Vogel W, Schreiber F.

Endoscopy. 2008 Aug;40(8):625-30. doi: 10.1055/s-2008-1077461.

PMID:
18680074
7.

Predicting native papilla biliary cannulation success using a multinational Endoscopic Retrograde Cholangiopancreatography (ERCP) Quality Network.

Peng C, Nietert PJ, Cotton PB, Lackland DT, Romagnuolo J.

BMC Gastroenterol. 2013 Oct 10;13:147. doi: 10.1186/1471-230X-13-147.

8.

Prospective analysis of fluoroscopy duration during ERCP: critical determinants.

Kim E, McLoughlin M, Lam EC, Amar J, Byrne M, Telford J, Enns R.

Gastrointest Endosc. 2010 Jul;72(1):50-7. doi: 10.1016/j.gie.2010.04.012.

PMID:
20620272
9.

Are you safe for your patients - how many ERCPs should you be doing?

Guda NM, Freeman ML.

Endoscopy. 2008 Aug;40(8):675-6. doi: 10.1055/s-2008-1077486. No abstract available.

PMID:
18680079
10.

Measures of patient radiation exposure during endoscopic retrograde cholangiography: beyond fluoroscopy time.

Kachaamy T, Harrison E, Pannala R, Pavlicek W, Crowell MD, Faigel DO.

World J Gastroenterol. 2015 Feb 14;21(6):1900-6. doi: 10.3748/wjg.v21.i6.1900.

11.

Radiation doses to ERCP patients are significantly lower with experienced endoscopists.

Jorgensen JE, Rubenstein JH, Goodsitt MM, Elta GH.

Gastrointest Endosc. 2010 Jul;72(1):58-65. doi: 10.1016/j.gie.2009.12.060. Epub 2010 Apr 24.

12.

Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation.

Kapral C, Mühlberger A, Wewalka F, Duller C, Knoflach P, Schreiber F; Working Groups Quality Assurance and Endoscopy of Austrian Society of Gastroenterology and Hepatology (OeGGH).

Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1447-54. doi: 10.1097/MEG.0b013e3283583c6f.

PMID:
23114747
13.

Anatomical Location of Pathology Is Predictive of Prolonged Fluoroscopy Time During ERCP: A Multicenter American Study.

Alkhatib AA, Abdel Jalil AA, Faigel DO, Pannala R, Crowell M, Harrison ME.

Dig Dis Sci. 2015 Jun;60(6):1787-92. doi: 10.1007/s10620-014-3508-5. Epub 2015 Feb 4.

PMID:
25648640
14.

Time-limited fluoroscopy to reduce radiation exposure during ERCP: a prospective randomized trial.

Uradomo LT, Goldberg EM, Darwin PE.

Gastrointest Endosc. 2007 Jul;66(1):84-9.

PMID:
17591479
15.

Improving ERCP quality and decreasing risk to patients and providers.

Kachaamy TA, Faigel DO.

Expert Rev Gastroenterol Hepatol. 2013 Aug;7(6):531-40. doi: 10.1586/17474124.2013.824703. Review.

PMID:
23985002
16.

Endoscopic retrograde cholangiopancreatography after a liquid fatty meal: effect on deep common bile duct cannulation time.

Barrie M, Klein SD, Brown CA, Edge MD, Affronti JA, Cai Q.

Endoscopy. 2006 Mar;38(3):241-8.

PMID:
16528650
17.

A prospective analysis of factors influencing fluoroscopy time during therapeutic ERCP.

Katsinelos P, Gatopoulou A, Gkagkalis S, Fasoulas K, Beltsis A, Zavos C, Terzoudis S, Lazaraki G, Chatzimavroudis G, Vasiliadis I, Kountouras J.

Ann Gastroenterol. 2012;25(4):338-344.

18.

Endoscopist administered sedation during ERCP: impact of chronic narcotic/benzodiazepine use and predictive risk of reversal agent utilization.

Papachristou GI, Gleeson FC, Papachristou DJ, Petersen BT, Baron TH.

Am J Gastroenterol. 2007 Apr;102(4):738-43. Epub 2007 Feb 23.

PMID:
17324132
19.

ERCP and fluoroscopy use: is experience the difference?

Sun JG, Faulx AL.

Gastrointest Endosc. 2010 Jul;72(1):66-7. doi: 10.1016/j.gie.2010.03.1116. No abstract available.

PMID:
20620273
20.

Guideline on training and credentialing in endoscopic retrograde cholangiopancreatography.

Ang TL, Cheng J, Khor JL, Mesenas SJ, Vu KF, Wong WK; Endoscopic Retrograde Cholangiopancreatography (ERCP).

Singapore Med J. 2011 Sep;52(9):654-7.

Supplemental Content

Support Center